GSK Fined £38m For ‘Stifling’ Drug Competition
Drug giant GlaxoSmithKline (GSK) has been fined £37.6m for “illegal behaviour designed to stifle competition at the expense of the…
Drug giant GlaxoSmithKline (GSK) has been fined £37.6m for “illegal behaviour designed to stifle competition at the expense of the…